his educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, pathologists, and other healthcare providers involved or interested in the diagnosis, treatment, and management of patients with breast cancer.
Objectives
Discuss the most clinically relevant and ground-breaking data presented at the 32nd Annual San Antonio Breast Cancer Symposium and integrate this emerging data into clinical practice
Describe novel ways to personalize breast cancer therapy by incorporating new advances in gene profiling and prognostic markers
Discuss the relevance of extranuclear receptor signaling to patient stratification for chemotherapeutic and endocrine therapy response and resistance
Determine how the microenvironment and host-related factors can contribute to the disease progression of breast cancer, and ways to exploit this knowledge
Evaluate promising novel targeted and epigenetic therapeutic strategies for the treatment of breast cancer, focusing on the benefits and limitations of these treatment regimens
Debate the controversies in neoadjuvant and adjuvant therapy and analyze the efficacy of these agents in specific clinical scenarios
Analyze emerging data on the use of bisphosphonates from trials assessing outcomes on bone health in breast cancer patients
Past Events
Breast Cancer 2010: Advances in Science, Emerging Data and Novel Therapeutics - 23 Jan 2010, Westin Buckhead Atlanta hotel, Georgia, United States (2641)
Breast Cancer : Advances in Science, Emerging Data and Novel Therapeutics 2026
Important
Please, check "Breast Cancer : Advances in Science, Emerging Data and Novel Therapeutics" official website for possible changes, before making any traveling arrangements
